Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben F Ørntoft

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Oncotarget|April 28, 2016
Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profilingHelle Kristensen, Anni R Thomsen, Christa Haldrup, et al.
BMC Medical Genomics|September 8, 2012
miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancerIver Nordentoft, Karin Birkenkamp-Demtroder, Mads Agerbæk, et al.
Molecular & Cellular Proteomics : MCP|July 4, 2002
Proteomic strategies to reveal tumor heterogeneity among urothelial papillomasJulio E Celis, Pamela Celis, Hildur Palsdottir, et al.
Cancer Research|December 17, 2008
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrestChristian J Braun, Xin Zhang, Irina Savelyeva, et al.
BMC Cancer|November 26, 2010
Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcriptsAnne Sofie Brems-Eskildsen, Karsten Zieger, Helle Toldbod, et al.
Molecular Oncology|September 2, 2016
Spatial and temporal clonal evolution during development of metastatic urothelial carcinomaMathilde B H Thomsen, Iver Nordentoft, Philippe Lamy, et al.
Plos One|January 20, 2011
Pressure load: the main factor for altered gene expression in right ventricular hypertrophy in chronic hypoxic ratsJonas D Baandrup, Lars H Markvardsen, Christian D Peters, et al.
European Urology|January 25, 2016
Genomic Alterations in Liquid Biopsies from Patients with Bladder CancerKarin Birkenkamp-Demtröder, Iver Nordentoft, Emil Christensen, et al.
Scientific Reports|September 17, 2017
Comprehensive multiregional analysis of molecular heterogeneity in bladder cancerMathilde Borg Houlberg Thomsen, Iver Nordentoft, Philippe Lamy, et al.
European Urology|February 19, 2011
High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomyJørgen Bjerggaard Jensen, Pia Pinholt Munksgaard, Christoffer Mørk Sørensen, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Oncotarget|April 28, 2016
Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profilingHelle Kristensen, Anni R Thomsen, Christa Haldrup, et al.
BMC Medical Genomics|September 8, 2012
miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancerIver Nordentoft, Karin Birkenkamp-Demtroder, Mads Agerbæk, et al.
Molecular & Cellular Proteomics : MCP|July 4, 2002
Proteomic strategies to reveal tumor heterogeneity among urothelial papillomasJulio E Celis, Pamela Celis, Hildur Palsdottir, et al.
Cancer Research|December 17, 2008
p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrestChristian J Braun, Xin Zhang, Irina Savelyeva, et al.
BMC Cancer|November 26, 2010
Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcriptsAnne Sofie Brems-Eskildsen, Karsten Zieger, Helle Toldbod, et al.
Molecular Oncology|September 2, 2016
Spatial and temporal clonal evolution during development of metastatic urothelial carcinomaMathilde B H Thomsen, Iver Nordentoft, Philippe Lamy, et al.
Plos One|January 20, 2011
Pressure load: the main factor for altered gene expression in right ventricular hypertrophy in chronic hypoxic ratsJonas D Baandrup, Lars H Markvardsen, Christian D Peters, et al.
European Urology|January 25, 2016
Genomic Alterations in Liquid Biopsies from Patients with Bladder CancerKarin Birkenkamp-Demtröder, Iver Nordentoft, Emil Christensen, et al.
Scientific Reports|September 17, 2017
Comprehensive multiregional analysis of molecular heterogeneity in bladder cancerMathilde Borg Houlberg Thomsen, Iver Nordentoft, Philippe Lamy, et al.
European Urology|February 19, 2011
High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomyJørgen Bjerggaard Jensen, Pia Pinholt Munksgaard, Christoffer Mørk Sørensen, et al.
Pageof 8